This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SEC Rules In Favor Of Ronald L. Chez Proxy Proposal

CHICAGO, April 19, 2012 /PRNewswire/ -- The SEC ruled on April 17, 2012 that the proxy proposal submitted by Mr. Ronald L. Chez, an owner of 9.2% of RGEN's stock, cannot be excluded from Repligen's (Nasdaq: RGEN) proxy statement.

The proposal calls for shareholders to be able to call a special meeting with a 20% favorable vote, rather than the 50% requirement currently in place.

Mr. Chez said, "I believe this proposal will be beneficial for Repligen and its shareholders to help assure that the Board is acting in alignment with shareholder interests and concerns, and consistent with the steps necessarily to build a successful operating company. Amongst other actions, the Board needs to implement multi variable compensation plans that directly reward management performance that will benefit shareholders, i.e. profit, return on equity, stock price, etc."

Mr. Chez continued, "Repligen has a significant opportunity to finally achieve important, positive results that can benefit patients, Repligen employees and shareholders."

SOURCE Ronald L. Chez

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs